,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,KEGG_2021_Human__Ribosome,-0.683938903697755,-2.6903504263108253,0.0,0.0,0.0,57/97,13.53%,RPL31;MRPS15;RPS28;RPL7;RPS8;RPL3;MRPS21;RPL10;RPS4Y2;RPS27A;RPL8;RPS26;RPS6;RPL12;RPLP0;RPL35A;RPL6;RPL26;RPL10A;RPLP1;MRPL16;RPS3A;RPL22L1;RPL18;RPL18A;RPS15;RPL4;RPS25;RPL14;RPS17;RPS23;RPLP2;RPS2;RPS20;RPL15;RPS15A;RPL23A;RPL29;RPS19;MRPL23;RPL9;RPL13;RPL30;RPS29;MRPS9;RPL22;RPL34;MRPS12;RPS5;RPL23;RPS16;RPL27A;RPS7;RPL35;MRPL24;RPL19;RPS18
1,prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.881441830625035,2.0892164556688835,0.0,0.0,0.0,51/74,6.90%,IFI27;RTP4;IRF7;UBE2L6;LGALS3BP;HERC6;GBP2;TMEM140;IFIT2;TRAFD1;PSMB9;ISG20;ISG15;IFI44;IFIT3;BST2;OASL;TAP1;SAMD9L;PARP9;IFIH1;NMI;DHX58;SAMD9;OGFR;PARP14;DDX60;UBA7;HELZ2;PSMB8;TRIM21;MX1;CXCL10;CNP;ADAR;SP110;STAT2;EIF2AK2;B2M;IRF9;CSF1;RSAD2;CCRL2;PARP12;PSME1;EPSTI1;CMPK2;GBP4;TRIM5;IRF1;MOV10
2,prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.8429629490715327,2.0606207009448148,0.0,0.0,0.0,79/127,10.66%,IFI27;RTP4;IRF7;UBE2L6;LGALS3BP;HERC6;XAF1;IFIT2;TRAFD1;PSMB9;ISG20;ISG15;DDX58;IFI44;IFIT3;BST2;OASL;TAP1;SAMD9L;IFIH1;NMI;DHX58;OGFR;PARP14;RNF213;OAS2;ZNFX1;FPR1;DDX60;UPP1;HELZ2;PSMB8;TRIM21;MX1;CDKN1A;CXCL10;ADAR;SP110;CD274;STAT2;NAMPT;FAS;OAS3;SERPING1;EIF2AK2;B2M;IRF9;NLRC5;RSAD2;GBP6;STAT1;PARP12;PSME1;SOD2;ZBP1;EPSTI1;VAMP8;CMPK2;GBP4;PSMB10;IRF1;PTGS2;SAMHD1;TDRD7;SOCS1;SRI;GCH1;CMTR1;MYD88;CASP3;ICAM1;WARS1;PML;TNFSF10;PELI1;RIPK1;TRIM26;PSME2;RBCK1
3,prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.7427227619349486,-2.0346526653760044,0.0,0.008129155660806995,0.007,8/17,6.17%,NR4A1;PRKACB;CALM3;ADCY7;NR4A2;GNAS;ATP1B3;ATP2B1
4,prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4947838916234946,-2.001134544577523,0.0,0.008516258311321615,0.011,48/108,17.12%,ERH;PABPC1;RPS6;EEF1B2;RPLP0;RPL6;SRSF7;EPRS1;RPL18;GSPT1;VDAC3;NAP1L1;RPL14;IMPDH2;G3BP1;HSPE1;HSPD1;NOP56;RPS2;PA2G4;RACK1;MRPL23;SRPK1;SRSF2;USP1;PSMB2;TCP1;NPM1;SERBP1;RPL22;RPL34;SET;RPS5;DEK;CCT2;SLC25A3;RANBP1;COX5A;U2AF1;CANX;EIF3B;PHB2;CCT5;DHX15;CCT4;SF3B3;SRSF3;TRIM28
5,prerank,KEGG_2021_Human__Amphetamine addiction,-0.6792599129978889,-1.879663177599811,0.005681818181818182,0.017419619273157848,0.029,4/17,2.74%,PRKACB;CALM3;FOSB;GNAS
6,prerank,KEGG_2021_Human__Calcium signaling pathway,-0.5875226955633387,-1.8331200744866678,0.007936507936507936,0.018580927224701706,0.039,12/28,12.65%,PRKACB;CALM3;ADCY7;GNAS;SLC25A5;VDAC3;SLC25A4;ATP2B1;PPP3CB;ATP2A2;RET;ADRB2
7,prerank,KEGG_2021_Human__Melanogenesis,-0.6402940072037697,-1.821743298741463,0.0,0.01703251662264323,0.041,4/19,2.74%,PRKACB;CALM3;ADCY7;GNAS
8,prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.5223177027884468,-1.7945105176427745,0.0,0.020239938584050068,0.055,7/40,5.88%,NCOA3;PRKACB;CALM3;ADCY7;GNAS;FKBP4;PIK3CD
9,prerank,KEGG_2021_Human__Hepatitis C,0.7251436257564022,1.7405508629769884,0.0,0.027487176690510602,0.069,21/71,10.74%,IRF7;DDX58;OAS2;TNFRSF1A;MX1;CDKN1A;CXCL10;STAT2;FAS;OAS3;EIF2AK2;IRF9;RSAD2;STAT1;CLDN1;CASP3;BID;CLDN5;CFLAR;RIPK1;BAK1
10,prerank,KEGG_2021_Human__Influenza A,0.7006065646970904,1.7157287093060902,0.0010193679918450561,0.035371656320157055,0.107,28/83,10.74%,IRF7;DDX58;IFIH1;OAS2;TNFRSF1A;MX1;CXCL10;ADAR;STAT2;FAS;OAS3;EIF2AK2;IRF9;RSAD2;STAT1;DNAJC3;RAB11A;MYD88;CASP3;BID;IFNGR1;ICAM1;PML;TNFSF10;ACTG1;TMPRSS4;CCND3;BAK1
11,prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.7369001642102215,1.6939602660340403,0.002145922746781116,0.043400805300806214,0.149,24/42,14.43%,CSF3R;TLR2;TNFRSF1A;CXCL10;STAT2;FAS;IRF9;CSF1;STAT1;IL13RA1;IRF1;CSF2RA;SOCS1;MYD88;IL10RB;IFNGR1;IL17RA;BAK1;CCR1;IL15RA;IL1R2;SOCS3;HMOX1;IL18R1
12,prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.7015262513594681,1.6771706812110163,0.0,0.04831956323489758,0.184,35/88,14.43%,RTP4;IRF7;BST2;CLEC5A;NMI;CSF3R;FPR1;TLR2;P2RY2;CDKN1A;CXCL10;NAMPT;MXD1;EIF2AK2;CSF1;CCRL2;SLC31A2;RHOG;IRF1;TNFSF9;FFAR2;NOD2;SRI;GCH1;ICAM1;TNFSF10;PTAFR;TIMP1;IL15RA;CD55;C3AR1;PDE4B;RIPK2;PROK2;IL18R1
13,prerank,KEGG_2021_Human__Measles,0.686931703997706,1.655161103369002,0.0,0.06026511821769091,0.247,19/71,10.74%,IRF7;DDX58;IFIH1;OAS2;TLR2;MX1;ADAR;STAT2;FAS;OAS3;EIF2AK2;IRF9;STAT1;MYD88;CASP3;STAT5B;BID;CCND3;BAK1
14,prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.744779426320199,1.6466380229018989,0.005649717514124294,0.06054412339462466,0.277,8/31,3.47%,IRF7;ISG15;DDX58;IFIH1;DHX58;MAPK13;CXCL10;OTUD5
15,prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.46652835658607,-1.6347173542968838,0.0,0.07867861371709627,0.205,12/42,12.65%,MEF2C;CALM3;ADCY7;SLC25A5;VDAC3;ATP1B3;SLC25A4;ATP2B1;MEF2D;PPP3CB;ATP2A2;ADRB2
16,prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.664455844415168,1.6076973457912502,0.0010162601626016261,0.09654268023579336,0.426,24/87,10.74%,IRF7;DDX58;BST2;TAP1;IFIH1;OAS2;TLR2;TNFRSF1A;STAT2;FAS;OAS3;EIF2AK2;B2M;IRF9;TAP2;STAT1;PILRA;EIF4EBP1;MYD88;CASP3;BID;IFNGR1;PML;BAK1
17,prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.6663883364881127,1.605186699293812,0.00102880658436214,0.08897165086665272,0.431,30/76,19.67%,IRF7;IFI16;GBP2;GBP7;MAPK13;OAS2;GSDMD;STAT2;NAMPT;OAS3;IRF9;GABARAP;STAT1;CYBA;GBP4;NOD2;MYD88;RIPK1;RBCK1;CAMP;RIPK2;TLR4;NFKBIB;MCU;BIRC3;GABARAPL1;ATG12;NFKBIA;TRPM2;ANTXR2
18,prerank,KEGG_2021_Human__Renin secretion,-0.5944904558531399,-1.5996181457776117,0.015,0.08877554118468592,0.244,5/15,12.65%,PRKACB;CALM3;GNAS;PPP3CB;ADRB2
19,prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.6501416041920053,1.5898102101137304,0.0,0.09903274664093054,0.504,26/109,10.74%,IRF7;ISG15;DDX58;TAP1;MAPK13;OAS2;TLR2;CDKN1A;CXCL10;STAT2;FAS;OAS3;EIF2AK2;B2M;IRF9;TAP2;STAT1;SAP30;MYD88;CASP3;BID;ICAM1;CCND3;RIPK1;PSMD8;BAK1
20,prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.6878891841485721,1.5717764905403364,0.007616974972796518,0.11436112196762437,0.574,16/42,14.16%,CSF3R;CDKN1A;STAT2;IRF9;STAT1;IL13RA1;CSF2RA;SOCS1;STAT5B;IL10RB;IFNGR1;CCND3;IL15RA;SOCS3;MCL1;PTPN6
21,prerank,KEGG_2021_Human__TNF signaling pathway,0.655454693577679,1.5371036371867874,0.009574468085106383,0.16098360243114426,0.705,18/52,16.13%,MAPK13;TNFRSF1A;CXCL10;FAS;CSF1;IRF1;PTGS2;CEBPB;NOD2;CASP3;ICAM1;CFLAR;RIPK1;MMP9;BCL3;SOCS3;IL18R1;BIRC3
22,prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.5167004756985568,-1.535148013059924,0.014925373134328358,0.12844065944075053,0.351,10/26,12.56%,CITED2;NEK7;ZMIZ1;PIK3CD;ATP2B1;BHLHE40;PHF3;CDKN1B;SMAD7;PRDM2
23,prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.6268327164558171,1.528622848453957,0.0030737704918032786,0.16349703368317997,0.736,19/86,10.74%,BST2;TAP1;ELOB;MAPK13;TLR2;TNFRSF1A;FAS;CFL1;B2M;TAP2;GNG10;TRIM5;SAMHD1;LIMK2;MYD88;CASP3;BID;RIPK1;BAK1
24,prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.628200809394726,1.5209115770960697,0.0,0.16665909235509585,0.759,33/89,14.16%,IRF7;GBP2;SRGN;TAP1;TLR2;FAS;B2M;CSF1;TAP2;STAT1;IGSF6;RPS9;C2;CTSS;HCLS1;PSMB10;SPI1;SOCS1;IFNGR1;ICAM1;WARS1;CCND3;TIMP1;CCR1;DEGS1;NCF4;FGR;FYB1;MMP9;BCL3;RIPK2;FCGR2B;PTPN6
25,prerank,KEGG_2021_Human__Proteasome,0.667563295376584,1.5056703291322449,0.01425438596491228,0.1838566614555403,0.81,8/38,10.49%,PSMB9;PSMB8;PSMA5;PSME1;POMP;PSMB10;PSMD8;PSME2
26,prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.7152550810709544,1.5010165291929896,0.026221692491060787,0.18136430638642784,0.816,7/22,11.71%,IRF7;DDX58;CXCL10;ADAR;ZBP1;RIPK1;POLR1D
27,prerank,KEGG_2021_Human__Hepatitis B,0.6238891820501554,1.4957577404048557,0.011398963730569948,0.18141536615736994,0.832,13/71,9.01%,IRF7;DDX58;IFIH1;MAPK13;TLR2;CDKN1A;STAT2;FAS;STAT1;MYD88;CASP3;STAT5B;BID
28,prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6099612727713548,1.4893694982080243,0.003036437246963563,0.18397372941720697,0.847,36/109,14.14%,IFIT2;PLEK;DDX58;TAP1;IFIH1;CEBPD;TLR2;CDKN1A;CXCL10;NAMPT;MXD1;ETS2;CSF1;CCRL2;SOD2;SLC2A6;BCL2A1;SQSTM1;IRF1;TNFSF9;PTGS2;PNRC1;CEBPB;GCH1;ICAM1;CFLAR;IL15RA;EHD1;BCL3;SOCS3;TNFAIP2;PDE4B;MCL1;RIPK2;NFIL3;LITAF
29,prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.6073211588305203,1.475579856713772,0.012345679012345678,0.20315916961307387,0.881,20/85,11.25%,IRF7;MAPK13;TNFRSF1A;CDKN1A;UBB;STAT2;FAS;EIF2AK2;IRF9;GABARAP;STAT1;GNG10;PTGS2;CASP3;BID;IFNGR1;ICAM1;CD200R1;BAK1;CCR1
30,prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.6182000750943825,1.4624205685263567,0.020674646354733407,0.220517425028382,0.912,17/49,14.82%,ELOB;PGK1;CDKN1A;ALDOA;LDHC;MKNK1;LDHA;HK3;SLC2A1;EIF4EBP1;IFNGR1;TIMP1;PFKL;EGLN2;HMOX1;TLR4;ELOC
31,prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.6875069091049311,1.4603099307088874,0.03762135922330097,0.21617546567556112,0.919,12/21,19.46%,PGK1;ALDOA;LDHC;PKM;LDHA;HK3;TPI1;ADPGK;PFKL;GPI;PGAM4;PDHB
32,prerank,KEGG_2021_Human__Necroptosis,0.6182056257659437,1.460100656394312,0.015592515592515593,0.20753132899924637,0.919,19/61,10.66%,FTH1;TNFRSF1A;STAT2;FAS;EIF2AK2;IRF9;CHMP5;STAT1;ZBP1;SQSTM1;STAT5B;BID;IFNGR1;CHMP2A;SMPD1;TNFSF10;CFLAR;RIPK1;RBCK1
33,prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.4372771451806175,-1.4452276158943735,0.05102040816326531,0.19995611456582402,0.513,6/35,2.74%,MAFB;PRKACB;MEF2C;ADCY7;NR4A2;GNAS
34,prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.615908237055903,1.438857791209945,0.023554603854389723,0.2475292595655981,0.957,26/48,24.73%,TNFRSF1A;CDKN1A;STAT2;CFL1;MKNK1;ARPC3;DAPP1;SQSTM1;SLC2A1;MYD88;RPS6KA1;SLA;RIPK1;PFN1;ARHGDIA;NFKBIB;CSNK2B;UBE2D3;PPP1CA;DDIT3;NCK1;RAF1;TBK1;GRK2;IRAK4;RIT1
35,prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.6221930035895609,1.4369000863977417,0.025157232704402517,0.24130847747248252,0.959,25/48,20.89%,IL1RN;CSF3R;TNFRSF1A;CXCL10;FAS;CSF1;CXCL16;IL13RA1;TNFSF9;CSF2RA;CXCR2;IL10RB;IFNGR1;TNFSF10;IL17RA;CCR1;IL15RA;IL1R2;IL18R1;CLCF1;IL16;LTBR;TNFSF14;CCL3L3;IL18RAP
36,prerank,MSigDB_Hallmark_2020__Apoptosis,0.6012233156026735,1.4310524392941346,0.017382413087934562,0.24411283719961152,0.964,28/73,20.57%,ISG20;TAP1;TSPO;CDKN1A;FAS;SOD2;SQSTM1;IRF1;DNAJC3;GCH1;CASP3;LGALS3;BID;IFNGR1;TNFSF10;DAP;HMGB2;CFLAR;TIMP1;ANXA1;MCL1;HMOX1;BIRC3;RARA;DDIT3;CD14;GPX1;CD44
37,prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.6128874184023946,1.4294266273254095,0.0322234156820623,0.23851153668643055,0.964,21/47,28.10%,IRF7;MAPK13;TLR2;CXCL10;STAT1;LBP;MYD88;RIPK1;TIRAP;TLR4;CD14;NFKBIA;CCL3L3;TBK1;IRAK4;SPP1;IL1B;RELA;IFNAR2;MAP2K3;IRF5
38,prerank,KEGG_2021_Human__Lysine degradation,-0.5238228387706039,-1.4251887804125796,0.06285714285714286,0.20942253392840876,0.557,11/18,27.88%,ALDH2;NSD1;PRDM2;EZH1;KMT2A;SETD2;KMT5A;ECHS1;DLD;ASH1L;KMT5B
39,prerank,KEGG_2021_Human__Osteoclast differentiation,0.6008739595906025,1.4251055209012555,0.03477344573234984,0.23901443490658278,0.969,17/59,14.09%,MAPK13;TYROBP;TNFRSF1A;NCF2;STAT2;IRF9;CSF1;STAT1;CYBA;SQSTM1;SPI1;SOCS1;IFNGR1;NCF4;SOCS3;LILRB2;FCGR2B
40,prerank,MSigDB_Hallmark_2020__E2F Targets,-0.3746260306357639,-1.409312759343028,0.017543859649122806,0.2131446747987417,0.591,16/52,11.95%,TUBB;PNN;CDC25B;SMC3;GSPT1;NAP1L1;ANP32E;RBBP7;NOP56;PA2G4;SRSF2;USP1;CDKN1B;DEK;SMC6;RANBP1
41,prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.4599285610466116,-1.4016130550135513,0.04697986577181208,0.20721051878261093,0.606,9/24,25.75%,ID2;SMAD4;ZFYVE16;RPS6KB1;SMAD7;ID3;SMAD2;TNF;TGFB1
42,prerank,KEGG_2021_Human__Circadian entrainment,-0.4973520297084144,-1.3959238003367358,0.07281553398058252,0.198041716003279,0.615,4/17,2.74%,PRKACB;CALM3;ADCY7;GNAS
43,prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.5205932305147094,-1.3950885698701054,0.06779661016949153,0.186244762728846,0.615,7/16,17.61%,PRKACB;ADCY7;GNAS;PIK3CD;ADRB2;AKT1;PIK3R1
44,prerank,KEGG_2021_Human__p53 signaling pathway,0.6425112368506284,1.3885405394714334,0.07398843930635839,0.32544617657632136,0.994,6/25,10.10%,SHISA5;CDKN1A;FAS;CASP3;BID;CCND3
45,prerank,KEGG_2021_Human__IL-17 signaling pathway,0.6133688136980315,1.3726160253589241,0.07752808988764046,0.3614708404153147,0.998,9/33,12.19%,MAPK13;CXCL10;LCN2;S100A9;PTGS2;CEBPB;CASP3;IL17RA;MMP9
46,prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.6671650944908736,1.3719614976310905,0.0745721271393643,0.351938530210215,0.998,9/19,14.45%,TSPO;FPR1;P2RY2;GPR35;F2RL2;PTAFR;S1PR4;C3AR1;LTB4R
47,prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.608669466713644,1.3619184497673211,0.08792497069167643,0.3709955088119541,0.999,12/29,22.32%,SLC16A3;LDHC;PKM;LDHA;HK3;SLC2A1;PFKL;PGAM4;PDHB;G6PD;RAF1;HIF1A
48,prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.6511183203894222,1.359814056172307,0.10411622276029056,0.36664474247753803,0.999,9/19,14.09%,FPR1;SELPLG;FCAR;C2;ICAM1;PTAFR;CAMP;C3AR1;FCGR2B
49,prerank,MSigDB_Hallmark_2020__Glycolysis,0.5696907199200413,1.354405849602719,0.07015706806282722,0.37166407268772755,1.0,12/55,6.66%,ISG20;SLC16A3;PGK1;ALDOA;LDHC;PKM;NT5E;LDHA;TPI1;IL13RA1;TALDO1;SAP30
50,prerank,KEGG_2021_Human__Toxoplasmosis,0.5743785888629821,1.3455099758422489,0.07311827956989247,0.3889456168757393,1.0,22/49,27.52%,MAPK13;TLR2;TNFRSF1A;STAT1;IRGM;SOCS1;MYD88;CASP3;IL10RB;IFNGR1;TLR4;NFKBIB;BIRC3;NFKBIA;ALOX5;IRAK4;STAT3;RELA;PIK3R5;GNAI2;MAP2K3;BAD
51,prerank,MSigDB_Hallmark_2020__Complement,0.5628058565690416,1.3429918324355627,0.05377456049638056,0.38590549379966854,1.0,26/78,15.35%,IRF7;PSMB9;PLEK;SERPING1;FCER1G;LAMP2;RHOG;MSRB1;C2;CTSS;IRF1;S100A9;CEBPB;CASP3;LGALS3;PFN1;TIMP1;MMP8;CD55;EHD1;CSRP1;FDX1;USP15;IRF2;PLA2G7;PPP4C
52,prerank,KEGG_2021_Human__Tuberculosis,0.5549379619913811,1.337351091469762,0.03979591836734694,0.39414969181559195,1.0,24/84,14.48%,MAPK13;TLR2;LSP1;TNFRSF1A;CLEC4E;FCER1G;STAT1;LBP;LAMP2;CTSS;CEBPB;NOD2;TCIRG1;CLEC7A;MYD88;CASP3;IL10RB;BID;IFNGR1;CAMP;TIRAP;RIPK2;FCGR2B;TLR4
53,prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.5724338585082381,1.3365316431412515,0.07049891540130152,0.3861072694734355,1.0,18/47,19.26%,DDX58;TNFRSF1A;LBP;BCL2A1;PTGS2;MYD88;ICAM1;CFLAR;RIPK1;TIRAP;TLR4;BIRC3;CSNK2B;TRIM25;LTBR;CD14;TNFSF14;NFKBIA
54,prerank,KEGG_2021_Human__Human papillomavirus infection,0.5490459747431926,1.3341616074333593,0.047522750252780584,0.38348506427327744,1.0,20/104,10.74%,ISG15;OASL;TNFRSF1A;MX1;CDKN1A;STAT2;FAS;EIF2AK2;PKM;IRF9;ATP6V1G1;STAT1;IRF1;PTGS2;TBPL1;EIF4EBP1;TCIRG1;CASP3;CCND3;BAK1
55,prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.6004146661189893,1.3271074999499064,0.11316397228637413,0.39601064796720625,1.0,13/27,27.23%,TNFRSF1A;PRKAB1;SLC2A1;SOCS3;ADIPOR2;NFKBIB;PRKAA1;NFKBIA;ACSL5;STAT3;RELA;TRADD;CPT1A
56,prerank,KEGG_2021_Human__Antigen processing and presentation,0.607632609466481,1.3246610403139187,0.10407239819004525,0.39399462763317245,1.0,6/26,10.49%,TAP1;B2M;TAP2;PSME1;CTSS;PSME2
57,prerank,KEGG_2021_Human__Dilated cardiomyopathy,-0.4736052642280806,-1.3241973979367971,0.12429378531073447,0.25944985882138627,0.727,6/16,7.02%,PRKACB;ITGA4;ADCY7;GNAS;LMNA;ITGB1
58,prerank,KEGG_2021_Human__Gap junction,-0.46608311770212213,-1.316929519609624,0.10240963855421686,0.2538103045207517,0.742,4/21,2.74%,TUBB;PRKACB;ADCY7;GNAS
59,prerank,KEGG_2021_Human__Leishmaniasis,0.575451884218127,1.3133081222207716,0.0935412026726058,0.420801807966531,1.0,13/41,15.76%,MAPK13;TLR2;NCF2;STAT1;CYBA;MARCKSL1;PTGS2;MYD88;IFNGR1;NCF4;PTPN6;TLR4;NFKBIB
60,prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.6086916818593691,1.3128989775053195,0.12270642201834862,0.4122067182523083,1.0,8/27,19.26%,MAPK13;ATP6V1G1;CXCR2;TCIRG1;CASP3;ATP6V0E1;CDC42;NFKBIA
61,prerank,KEGG_2021_Human__Prolactin signaling pathway,0.5935501996582008,1.3112118398741774,0.117096018735363,0.4079872974663515,1.0,6/29,13.14%,MAPK13;STAT1;IRF1;SOCS1;STAT5B;SOCS3
62,prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.558743684677417,1.3075131741486745,0.09375,0.4098772052608139,1.0,16/56,16.98%,UBE2L6;ELOB;UBA7;UBB;SOCS1;UBE2Q1;PML;UBE2M;SOCS3;ELOC;KEAP1;UBE2L3;BIRC3;CDC34;UBE2D3;UBE2B
63,prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.5573996103755334,1.3026522333363708,0.09839572192513368,0.4159684139352053,1.0,11/53,8.74%,MAPK13;LSP1;CLEC4E;STAT2;FCER1G;IRF9;STAT1;CLEC4D;IRF1;PTGS2;CLEC7A
64,prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.5433341449566762,1.2946792179190834,0.1044776119402985,0.43330625275213414,1.0,15/51,22.32%,MAPK13;TLR2;CD274;STAT1;MYD88;IFNGR1;TIRAP;BATF;PTPN6;TLR4;NFKBIB;CSNK2B;NFKBIA;RAF1;HIF1A
65,prerank,KEGG_2021_Human__Inflammatory bowel disease,0.6066796169125682,1.2669170872276838,0.163855421686747,0.5192183007486451,1.0,10/20,25.41%,TLR2;STAT1;NOD2;IFNGR1;IL18R1;TLR4;IL18RAP;STAT3;IL1B;RELA
66,prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.36494837024906135,-1.2587768400596593,0.08974358974358974,0.33237856002607846,0.826,8/45,4.13%,KLF10;HES1;KLF4;ELOVL5;NRIP1;NCOR2;FKBP4;DHRS3
67,prerank,KEGG_2021_Human__Tight junction,0.5409011112968971,1.2533929894784468,0.1430084745762712,0.5584886484565377,1.0,17/50,20.09%,TUBA4A;MYL6;PRKAB1;ARPC3;ARPC1B;HCLS1;CLDN1;CLDN5;ACTG1;RAB8A;ARPC5;MYL12A;MYL12B;CDC42;PRKAA1;ARPC1A;VASP
68,prerank,KEGG_2021_Human__Glutathione metabolism,0.6073394112482953,1.2522449382322813,0.20024721878862795,0.5510860653875169,1.0,10/17,30.26%,TXNDC12;MGST1;PGD;GSTP1;GCLM;GPX1;G6PD;ANPEP;GSTM1;GGCT
69,prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.6220859012321984,1.2513119809870263,0.19071518193224593,0.543939739846457,1.0,7/16,25.77%,ATP6V1G1;CLTA;TCIRG1;ATP6V0E1;STXBP1;NAPA;ATP6V1F
70,prerank,KEGG_2021_Human__Phagosome,0.5268584562175325,1.2501353084413314,0.12280701754385964,0.5378862112337994,1.0,18/68,14.48%,TAP1;TLR2;TUBA4A;NCF2;ATP6V1G1;TAP2;CYBA;FCAR;LAMP2;CTSS;TCIRG1;CLEC7A;ACTG1;NCF4;SFTPA2;ATP6V0E1;FCGR2B;TLR4
71,prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.5186432233103357,1.249054888994358,0.10092687950566426,0.5314715218175329,1.0,17/89,11.25%,TAP1;MAPK13;TNFRSF1A;CDKN1A;FAS;B2M;TAP2;GNG10;PTGS2;EIF4EBP1;CXCR2;CASP3;IL10RB;BID;RIPK1;BAK1;CCR1
72,prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.5311135374373696,1.2489068053616739,0.13847780126849896,0.5220795390240314,1.0,13/58,12.31%,MAPK13;FPR1;TLR2;GSDMD;NCF2;SELPLG;CYBA;SIGLEC9;CLEC7A;ACTG1;H3-3A;NCF4;CAMP
73,prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.514014510071327,1.2463831684247992,0.109072375127421,0.5205413677223604,1.0,32/87,25.41%,IRF7;MAPK13;TLR2;TNFRSF1A;NCF2;FAS;CYBA;LBP;SOD2;MYD88;CASP3;BID;ICAM1;TNFSF10;NCF4;MMP9;TIRAP;TLR4;CDC42;VAV1;DDIT3;CD14;NFKBIA;CCL3L3;CASP1;RAP1B;TBK1;IRAK4;RHOA;STAT3;IL1B;RELA
74,prerank,MSigDB_Hallmark_2020__UV Response Up,0.5194372347777212,1.236214444426325,0.1349124613800206,0.5455791232063489,1.0,17/68,14.02%,TAP1;TUBA4A;ALDOA;CNP;SOD2;SQSTM1;IRF1;TMBIM6;GCH1;CASP3;BID;ICAM1;CCND3;BAK1;ARRB2;HMOX1;MARK2
75,prerank,MSigDB_Hallmark_2020__Hypoxia,0.5180344348185535,1.2345522542101692,0.1382198952879581,0.5420684440307011,1.0,21/67,18.27%,ISG20;PGK1;CDKN1A;ALDOA;LDHC;LALBA;PLIN2;LDHA;TPI1;SAP30;SLC2A1;PNRC1;PLAC8;PFKL;UGP2;HMOX1;NFIL3;GPI;DUSP1;DDIT3;TPD52
76,prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.34862549851668123,-1.2339476820890067,0.1282051282051282,0.35930868020766915,0.864,6/48,5.88%,AGPAT3;CYTH4;ADCY7;GNAS;RRAS;PIK3CD
77,prerank,KEGG_2021_Human__Oocyte meiosis,-0.3585868115151808,-1.2320933543802046,0.1282051282051282,0.34562736653090964,0.867,10/38,13.46%,PRKACB;CALM3;ADCY7;SMC3;ANAPC11;SLK;CPEB2;PPP3CB;ANAPC4;ANAPC13
78,prerank,KEGG_2021_Human__Rheumatoid arthritis,0.5618963621460916,1.2248849339963304,0.18692660550458715,0.5666947908690787,1.0,7/30,14.48%,TLR2;ATP6V1G1;CSF1;TCIRG1;ICAM1;ATP6V0E1;TLR4
79,prerank,KEGG_2021_Human__RNA transport,-0.2980924804584697,-1.2243879888645524,0.041666666666666664,0.34290256605585867,0.875,29/70,28.76%,PABPC1;PNN;EIF3F;EIF4B;EIF4A3;EIF3E;SEH1L;EIF3B;ACIN1;EIF4G3;THOC7;UPF3B;RAE1;PAIP1;CYFIP2;SENP2;EIF3I;POP7;EIF4A2;NUP98;NCBP2;NUP107;ELAC1;MAGOH;PHAX;XPO1;ALYREF;RNPS1;EEF1A1
80,prerank,KEGG_2021_Human__Chagas disease,0.5246415771364435,1.2217045598860377,0.19073275862068967,0.568212170280589,1.0,7/49,10.20%,MAPK13;TLR2;TNFRSF1A;FAS;MYD88;IFNGR1;CFLAR
81,prerank,KEGG_2021_Human__Pertussis,0.5329356959645015,1.2175206623713555,0.20217391304347826,0.5738888484925605,1.0,17/39,26.55%,MAPK13;SERPING1;CFL1;C2;IRF1;MYD88;CASP3;SFTPA2;TIRAP;TLR4;CD14;CASP1;IRAK4;RHOA;IL1B;RELA;GNAI2
82,prerank,KEGG_2021_Human__GnRH signaling pathway,-0.40099893328302727,-1.213084114265628,0.14634146341463414,0.3484933687632912,0.888,4/24,2.74%,PRKACB;CALM3;ADCY7;GNAS
83,prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3587010747520849,-1.198003262917037,0.140625,0.36261840786956917,0.908,3/31,2.40%,KLF10;NCOR2;ID2
84,prerank,KEGG_2021_Human__Cushing syndrome,-0.3742664953820706,-1.197488094229247,0.168,0.34867109937152746,0.908,4/31,2.74%,NR4A1;PRKACB;ADCY7;GNAS
85,prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.5438162229994944,1.1943108267342502,0.23986486486486486,0.6489345327665463,1.0,13/28,22.71%,LSP1;SOD2;SBNO2;CDKN2D;MGST1;HMOX2;EGLN2;FES;NDUFS2;GCLM;G6PD;MSRA;SOD1
86,prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.2793001718913706,-1.1880630146977271,0.0,0.35134032103246055,0.915,32/120,13.43%,MRPS15;ATP5F1D;SLC25A5;VDAC3;MTX2;ISCA1;COX7B;ALAS1;NDUFA5;HTRA2;SLC25A4;NDUFA1;UQCR10;HSD17B10;ACADM;NDUFB5;ATP5MC1;ATP5MC3;MRPS12;MPC1;RHOT1;MDH1;SLC25A3;NDUFA4;MDH2;UQCRB;NDUFB4;TIMM50;ATP5MC2;COX5A;HSPA9;ATP5F1A
87,prerank,KEGG_2021_Human__Spliceosome,-0.312467718888269,-1.185984995622595,0.07142857142857142,0.3422847658661485,0.917,26/84,20.89%,SNRPF;LSM5;SRSF7;SRSF6;CRNKL1;BCAS2;SRSF2;CDC40;EIF4A3;HNRNPA1L2;RBMX;SRSF9;U2AF1;ISY1-RAB43;ACIN1;DHX15;SF3B3;SRSF3;HNRNPK;HNRNPM;SF3B1;PRPF38B;HSPA2;SNRNP70;SNRPC;SNRPA1
88,prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.4885518627286429,1.1793327190311629,0.17882836587872558,0.6958269110501192,1.0,33/85,26.09%,MAPK13;TUBA4A;TNFRSF1A;FAS;ARPC3;ARPC1B;HCLS1;TMBIM6;MYD88;CLDN1;CASP3;TNFSF10;CLDN5;ACTG1;RIPK1;BAK1;TIRAP;ARPC5;PTPN6;TLR4;NFKBIB;CDC42;NFKBIA;ARPC1A;NCK1;CASP1;ACTB;IRAK4;RHOA;IL1B;RELA;CYTH2;TRADD
89,prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.5034206380236348,1.176761079878181,0.22198505869797225,0.6943026605454687,1.0,18/51,21.08%,UPP1;TNFRSF1A;ARG2;FAS;ETS2;XDH;PSMB10;TMBIM6;LPIN2;GCH1;PGD;PMM1;HMOX1;POR;GABARAPL1;SERTAD1;BLVRB;SAR1B
90,prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.380290839792948,-1.1747761482326644,0.18620689655172415,0.35112975420608167,0.93,4/27,2.74%,PRKACB;CALM3;ADCY7;GNAS
91,prerank,MSigDB_Hallmark_2020__Coagulation,0.5306666125721854,1.1711127494886104,0.2608695652173913,0.7047341388234973,1.0,13/32,16.32%,PLEK;SERPING1;LAMP2;C2;F2RL2;TIMP1;MMP8;CSRP1;F12;MMP9;ANXA1;SIRT2;CTSE
92,prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.49630551193278266,1.1699954861347077,0.21003134796238246,0.6987930276247961,1.0,20/64,17.90%,CXCL10;CST7;MXD1;CSF1;NT5E;GBP4;PLIN2;SOCS1;CASP3;F2RL2;IFNGR1;TNFSF10;CCND3;IL1R2;BATF;NFIL3;IL18R1;MAPKAPK2;GABARAPL1;ADAM19
93,prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,0.49515182448611617,1.1580538626213315,0.2431578947368421,0.7341180457835461,1.0,15/50,18.24%,MAPK13;TNFRSF1A;NCF2;CYBA;SQSTM1;MGST1;ICAM1;ACTG1;IL1R2;MMP9;HMOX1;KEAP1;GSTP1;DUSP1;PRKAA1
94,prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,0.505697619820766,1.1550994657633382,0.2613009922822492,0.7339011399044986,1.0,11/40,18.05%,TYROBP;FAS;FCER1G;CASP3;BID;IFNGR1;ICAM1;TNFSF10;PTPN6;VAV1;LCP2
95,prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.3525150315122668,-1.1538419663271389,0.22018348623853212,0.3771447685393118,0.939,6/33,7.00%,KLF4;ID2;REST;SMAD4;PIK3CD;JARID2
96,prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.5147386498245091,1.1536113861571249,0.2745762711864407,0.7293760629655194,1.0,4/32,9.21%,MAPK13;STAT1;STAT5B;IFNGR1
97,prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.5397075903319486,1.1534231014882659,0.28620689655172415,0.7195727719438015,1.0,9/26,19.67%,FABP5;S100A11;CXCL16;PNRC1;LGALS3;ACTG1;NFIL3;ETHE1;ANTXR2
98,prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.5196854595213578,1.1472154054572512,0.2940503432494279,0.7322087861148586,1.0,3/28,4.54%,MAPK13;FCER1G;ALOX5AP
99,prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.5442123807867206,1.1455320555055641,0.3068720379146919,0.7276297828417136,1.0,12/22,20.89%,TNFRSF1A;CXCL10;CSF1;CXCR2;IL10RB;TNFSF10;CCR1;IL18R1;LTBR;TNFSF14;CCL3L3;IL18RAP
100,prerank,KEGG_2021_Human__Renal cell carcinoma,0.5040163250587556,1.1322991980613026,0.2954292084726867,0.7676155764202591,1.0,10/37,22.64%,ELOB;CDKN1A;SLC2A1;EGLN2;ELOC;CDC42;TFE3;RAF1;HIF1A;RAP1B
101,prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.3431871212585214,-1.1300130380438467,0.21774193548387097,0.41427725658074505,0.956,11/29,17.61%,PRKACB;ADCY7;CDC25B;ANAPC11;PIK3CD;CPEB2;ANAPC4;ANAPC13;AKT1;RPS6KA3;PIK3R1
102,prerank,KEGG_2021_Human__Drug metabolism,0.5613626705912047,1.128128496044592,0.34892541087231355,0.7741157883557224,1.0,4/16,8.57%,UPP1;XDH;IMPDH1;MGST1
103,prerank,KEGG_2021_Human__Insulin resistance,0.49422469861525065,1.1261394709879569,0.3104972375690608,0.7713144198269766,1.0,19/40,27.71%,TNFRSF1A;PRKAB1;SLC2A1;RPS6KA1;PPP1R3B;SOCS3;OGA;SLC27A4;PPP1CA;NR1H2;PRKAA1;NFKBIA;PPP1R3D;MLX;CRTC2;STAT3;RELA;CPT1A;PYGL
104,prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.49214956411716615,1.1248148046893078,0.31871657754010696,0.7661110151698312,1.0,20/46,27.01%,MAPK13;NCF2;CYBA;CLDN1;ICAM1;CLDN5;ACTG1;NCF4;MMP9;MYL12A;MYL12B;CDC42;VAV1;VASP;RAP1B;ACTB;RASSF5;RHOA;GNAI2;CTNNA1
105,prerank,KEGG_2021_Human__Apoptosis,0.466992394315783,1.1234737870626845,0.29136316337148804,0.7608503807167915,1.0,13/68,10.74%,TUBA4A;TNFRSF1A;FAS;BCL2A1;CTSS;CASP3;BID;TNFSF10;ACTG1;CFLAR;RIPK1;LMNB1;BAK1
106,prerank,KEGG_2021_Human__Apelin signaling pathway,-0.32349932003189585,-1.1174400561810298,0.19753086419753085,0.42301578673655577,0.959,8/45,6.63%,PRKACB;MEF2C;CALM3;RPS6;ADCY7;RRAS;SMAD4;MEF2D
107,prerank,KEGG_2021_Human__Bladder cancer,0.5429488931052023,1.1167313104754468,0.36421319796954316,0.7755780271936279,1.0,5/18,29.90%,CDKN1A;MMP9;RAF1;E2F2;NRAS
108,prerank,KEGG_2021_Human__Viral carcinogenesis,0.4613460816814787,1.1116682457972589,0.30666666666666664,0.7834179209143989,1.0,10/77,10.74%,IRF7;CDKN1A;EIF2AK2;PKM;IRF9;TBPL1;CASP3;STAT5B;CCND3;BAK1
109,prerank,KEGG_2021_Human__Salmonella infection,0.44975170587145336,1.0983310027084772,0.27895266868076535,0.8229561813228061,1.0,45/123,27.47%,MAPK13;TLR2;DYNLT1;GSDMD;TUBA4A;TNFRSF1A;ARPC3;ARPC1B;RHOG;ARL8A;MYD88;CASP3;TNFSF10;ACTG1;RIPK1;PFN1;BAK1;TIRAP;ARPC5;RIPK2;TLR4;MYL12A;BIRC3;MYL12B;RAB7A;CDC42;CD14;NFKBIA;ARPC1A;FYCO1;RAF1;DCTN5;CASP1;ACTB;IRAK4;RHOA;IL1B;TXN2;RELA;CYTH2;TRADD;RAB5A;TUBB4B;DCTN1;MAP2K3
110,prerank,KEGG_2021_Human__Ferroptosis,0.5241964576577687,1.0965109344506894,0.3671497584541063,0.8193312526699449,1.0,8/19,22.10%,FTH1;HMOX1;SLC3A2;SLC7A11;SLC40A1;GCLM;ACSL5;MAP1LC3A
111,prerank,KEGG_2021_Human__FoxO signaling pathway,0.46918019560779384,1.0950215835504438,0.35074626865671643,0.8147134873578007,1.0,12/54,18.24%,MAPK13;CDKN1A;GABARAP;PRKAB1;SOD2;CDKN2D;TNFSF10;S1PR4;GABARAPL1;SGK3;ATG12;PRKAA1
112,prerank,KEGG_2021_Human__Viral myocarditis,0.5428496608003206,1.0867230096051488,0.40298507462686567,0.8352008629838072,1.0,5/16,11.42%,CASP3;BID;ICAM1;ACTG1;CD55
113,prerank,MSigDB_Hallmark_2020__p53 Pathway,0.443003196705707,1.0729742213496982,0.358739837398374,0.8755249682344323,1.0,19/93,15.38%,TRAFD1;TAP1;UPP1;CDKN1A;FAS;MXD1;PRKAB1;VAMP8;TNFSF9;SOCS1;STOM;CCND3;SERTAD3;BAK1;PMM1;RPS12;HMOX1;SLC3A2;SLC7A11
114,prerank,KEGG_2021_Human__Th17 cell differentiation,0.46610657708799413,1.0721256741026854,0.38393839383938394,0.868047106591339,1.0,12/40,26.60%,MAPK13;STAT1;STAT5B;IFNGR1;NFKBIB;RARA;NFKBIA;HIF1A;STAT3;IL1B;RELA;TGFBR1
115,prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.3880753249993921,-1.0604838977668685,0.35359116022099446,0.5427663038528099,0.983,2/16,3.11%,AGPAT3;ALDH2
116,prerank,MSigDB_Hallmark_2020__DNA Repair,0.44983461725766405,1.0530281928502918,0.4122533748701973,0.9283687552697159,1.0,22/63,29.97%,NT5C3A;POLD4;CMPK2;HCLS1;COX17;SDCBP;TAF12;POLR1D;PDE4B;ADRM1;TSG101;POLA2;NUDT9;ADA;CLP1;EDF1;SEC61A1;VPS28;TAF10;BCAP31;MPC2;TMED2
117,prerank,KEGG_2021_Human__Thyroid cancer,0.49385051534820146,1.0509098816733224,0.44004796163069543,0.9254767535922847,1.0,3/21,10.74%,CDKN1A;TPM3;BAK1
118,prerank,KEGG_2021_Human__PPAR signaling pathway,0.519894302054712,1.0473595393313049,0.4378769601930036,0.9276697646123359,1.0,3/18,5.81%,FABP5;SCP2;PLIN2
119,prerank,KEGG_2021_Human__Endocytosis,0.4328990294509077,1.0467078302226283,0.4040609137055838,0.9194756517557393,1.0,37/100,29.61%,CHMP5;ARPC3;ARPC1B;ARF5;CLTA;SMAP2;RAB11A;CXCR2;SNF8;PML;CHMP2A;EHD1;SH3GLB1;RAB8A;ARPC5;ARRB2;RNF103-CHMP3;RAB7A;CDC42;MVB12A;WASHC2C;ARPC1A;TSG101;EPN1;VPS29;GRK2;RHOA;CYTH2;RAB5A;TGFBR1;VPS25;PSD4;VPS28;SNX2;ARF1;IQSEC1;ACAP1
120,prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.42894881957957576,1.0438340190500013,0.42769857433808556,0.9189754785322394,1.0,23/91,21.50%,MAPK13;TNFRSF1A;FAS;UQCRHL;PRKAB1;CASP3;BID;NDUFB7;NDUFS6;SOCS3;NDUFA7;SDHB;NDUFB3;NDUFA13;ADIPOR2;CDC42;NDUFS2;DDIT3;PRKAA1;COX6B1;COX8A;NDUFA3;MLX
121,prerank,KEGG_2021_Human__Pathways in cancer,0.4228585053240922,1.0425748887255273,0.3985943775100402,0.912902183320558,1.0,32/150,16.61%,ELOB;CSF3R;CDKN1A;STAT2;FAS;STAT1;GNG10;IL13RA1;MAX;SLC2A1;SPI1;PTGS2;CSF2RA;MGST1;CASP3;STAT5B;BID;TPM3;IFNGR1;PML;CCND3;BAK1;IL15RA;EGLN2;MMP9;HMOX1;ELOC;KEAP1;GSTP1;BIRC3;RARA;CDC42
122,prerank,KEGG_2021_Human__Alcoholism,-0.308308705097598,-1.039891190009385,0.3804347826086957,0.5771348607672498,0.986,4/38,2.74%,PRKACB;CALM3;FOSB;GNAS
123,prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.5156548032068821,1.0368669114803997,0.44823232323232326,0.9223291137925617,1.0,5/16,14.38%,NPL;HK3;PMM1;UGP2;GPI
124,prerank,KEGG_2021_Human__RNA degradation,-0.3228260246562242,-1.0312464495824472,0.40310077519379844,0.5840012751616723,0.988,5/29,13.21%,PABPC1;LSM5;HSPD1;TOB1;HSPA9
125,prerank,KEGG_2021_Human__Long-term potentiation,-0.3619031222592072,-1.0231894433687443,0.37967914438502676,0.5874227421180696,0.989,2/19,1.48%,PRKACB;CALM3
126,prerank,KEGG_2021_Human__Shigellosis,0.41868817615523996,1.0202337400137322,0.4649746192893401,0.9701212179651079,1.0,38/113,26.09%,MAPK13;TNFRSF1A;UBB;GABARAP;ARPC3;ARPC1B;SQSTM1;HK3;HCLS1;MYD88;ACTG1;RIPK1;PFN1;RBCK1;H3-3A;ARPC5;RIPK2;TLR4;MYL12A;NFKBIB;MYL12B;UBE2V1;CDC42;UBE2D3;GABARAPL1;ATG12;CD14;NFKBIA;ARPC1A;CD44;CASP1;TBK1;ACTB;RHOA;IL1B;RELA;CYTH2;TRADD
127,prerank,KEGG_2021_Human__Yersinia infection,0.4230404894705932,1.0202189334986094,0.45304437564499483,0.9597458080583443,1.0,22/67,25.41%,MAPK13;ARPC3;ARPC1B;RHOG;MYD88;RPS6KA1;ACTG1;FYB1;ARPC5;TLR4;CDC42;VAV1;LCP2;NFKBIA;ARPC1A;CASP1;TBK1;ACTB;IRAK4;RHOA;IL1B;RELA
128,prerank,KEGG_2021_Human__VEGF signaling pathway,0.46290750455897156,0.9967205813886204,0.48708920187793425,1.0,1.0,4/24,16.61%,MAPK13;PTGS2;MAPKAPK2;CDC42
129,prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.4108794878079527,0.9941048366755942,0.514344262295082,1.0,1.0,13/88,12.12%,TSPO;TNFRSF1A;CDKN1A;ETS2;B2M;SLC2A1;SPI1;TBPL1;STAT5B;ICAM1;CCND3;IL15RA;IL1R2
130,prerank,KEGG_2021_Human__Proteoglycans in cancer,0.4220163567557396,0.9938249222211692,0.4989517819706499,1.0,1.0,14/65,17.42%,MAPK13;TLR2;CDKN1A;FAS;HCLS1;CASP3;ACTG1;CD63;MMP9;PTPN6;TLR4;CDC42;VAV1;PPP1CA
131,prerank,KEGG_2021_Human__Legionellosis,0.44800096771586845,0.9904968784482086,0.5158013544018059,1.0,1.0,13/30,28.49%,TLR2;MYD88;CASP3;TLR4;CD14;NFKBIA;SAR1B;CASP1;IL1B;RELA;CR1L;CLK4;ARF1
132,prerank,KEGG_2021_Human__Purine metabolism,0.4499058540162607,0.9904287063988314,0.5017026106696936,1.0,1.0,5/30,7.92%,NT5C3A;PKM;NT5E;XDH;IMPDH1
133,prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.40642496483158574,0.9887654541252052,0.5309644670050762,1.0,1.0,23/101,18.97%,TUBA4A;PGK1;CDKN1A;ALDOA;NAMPT;DAPP1;LDHA;SQSTM1;TPI1;SLC2A1;SLA;WARS1;IFRD1;PFKL;SERP1;NFIL3;GPI;SLC7A11;ADIPOR2;NFKBIB;UBE2D3;DDIT3;CORO1A
134,prerank,KEGG_2021_Human__Coronavirus disease,0.39997566540826685,0.9865462292565017,0.5326633165829145,0.9988608538369949,1.0,17/124,5.90%,ISG15;DDX58;IFIH1;MAPK13;OAS2;TLR2;TNFRSF1A;MX1;CXCL10;ADAR;STAT2;OAS3;EIF2AK2;IRF9;STAT1;RPS9;C2
135,prerank,KEGG_2021_Human__Glutamatergic synapse,-0.34671643356362825,-0.9832162406864007,0.4556213017751479,0.6805264596046999,0.994,5/19,11.59%,PRKACB;ADCY7;GNAS;GLUL;PPP3CB
136,prerank,MSigDB_Hallmark_2020__Apical Junction,0.42944567602399086,0.9822399393205695,0.5276008492569002,1.0,1.0,10/47,12.19%,MAPK13;CD274;ZYX;CAP1;ICAM1;CLDN5;ACTG1;PFN1;FYB1;MMP9
137,prerank,KEGG_2021_Human__Chemokine signaling pathway,0.40450569541778997,0.9720670163713906,0.5715767634854771,1.0,1.0,26/67,26.55%,CXCL10;STAT2;STAT1;GNG10;CXCL16;CXCR2;STAT5B;CCR1;FGR;ARRB2;NFKBIB;CDC42;VAV1;GNG5;NFKBIA;CCL3L3;GNB2;RAF1;RAP1B;GRK2;RHOA;STAT3;RELA;PIK3R5;GNB1;GNAI2
138,prerank,KEGG_2021_Human__Autophagy,0.40703551943141214,0.9718454403505173,0.5535524920466596,1.0,1.0,24/59,29.90%,GABARAP;VAMP8;LAMP2;SQSTM1;CFLAR;SH3GLB1;RAB8A;ATG16L2;MTMR3;RAB7A;GABARAPL1;ATG12;PRKAA1;MTMR14;RAF1;HIF1A;TBK1;RHEB;BAD;ATG4D;DDIT4;VMP1;ATG3;NRAS
139,prerank,KEGG_2021_Human__cAMP signaling pathway,-0.2826414032329568,-0.9703721205489435,0.527027027027027,0.6977891453708924,0.996,8/46,6.17%,PRKACB;CALM3;ADCY7;GNAS;ATP1B3;RRAS;PIK3CD;ATP2B1
140,prerank,KEGG_2021_Human__Glucagon signaling pathway,0.42963257488568124,0.9688649985345588,0.5456595264937993,1.0,1.0,10/32,19.46%,LDHC;PKM;PRKAB1;LDHA;SLC2A1;PFKL;PPP4C;PRKAA1;PGAM4;PDHB
141,prerank,KEGG_2021_Human__Small cell lung cancer,0.4310193909986023,0.9672631848740091,0.5428893905191874,1.0,1.0,7/31,19.26%,CDKN1A;MAX;PTGS2;CASP3;BAK1;BIRC3;NFKBIA
142,prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.41847144649276014,0.9643147542294613,0.5521064301552107,1.0,1.0,12/41,21.81%,CFL1;ARPC3;MARCKSL1;ARPC1B;LIMK2;ARPC5;FCGR2B;CDC42;VAV1;ARPC1A;VASP;RAF1
143,prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.4145185050233152,0.9616367595527698,0.5674217907227616,1.0,1.0,7/50,11.34%,MAPK13;TNFRSF1A;FCER1G;BID;SMPD1;S1PR4;DEGS1
144,prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.4630752770708768,0.9552327498239153,0.564134495641345,1.0,1.0,4/18,13.68%,LDHC;TALDO1;AGFG1;TLE4
145,prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.2876735668753965,-0.9522441690175573,0.5865384615384616,0.7251451335324375,0.998,7/32,12.87%,CALM3;MTMR1;PIK3CD;INPP4A;MTMR6;DGKH;IP6K2
146,prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.2650158816438593,-0.9299243582878344,0.6101694915254238,0.7679521043670784,1.0,11/48,20.55%,PABPC1;PNN;GSPT1;PAPOLA;EIF4A3;CPSF2;ACIN1;UPF3B;CPSF6;WDR82;PPP2R2D
147,prerank,KEGG_2021_Human__ErbB signaling pathway,0.4268858625442178,0.9198150160133071,0.6165680473372781,1.0,1.0,3/25,8.94%,CDKN1A;EIF4EBP1;STAT5B
148,prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.3710045113381816,0.9192616484908785,0.7147147147147147,1.0,1.0,39/205,20.28%,UBE2L6;MAPK13;UBA7;TUBA4A;TNFRSF1A;UBB;FAS;PSMA5;LRRK2;UQCRHL;CSF1;GABARAP;SQSTM1;PTGS2;CASP3;BID;NDUFB7;PSMD8;BAK1;NDUFS6;RAB8A;NDUFA7;SDHB;NDUFB3;NDUFA13;UBE2L3;MCU;CSNK2B;GABARAPL1;DNAH8;NDUFS2;DDIT3;COX6B1;ATP5PO;ADRM1;GPX1;PSMA1;COX8A;PSMA6
149,prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.3938022901311869,0.916083239644833,0.6410256410256411,1.0,1.0,17/46,24.70%,ISG20;FABP5;MAPK13;SNX10;S100A9;BATF;PTPN6;ITPK1;MOCS2;BAG1;CD44;BLVRB;CHPT1;ETFB;SIAH2;OLFM1;TSPAN13
150,prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,0.4142568954576008,0.9131159645539821,0.6377777777777778,1.0,1.0,8/33,16.61%,ARPC3;ARPC1B;RHOG;HCLS1;CLTA;ACTG1;ARPC5;CDC42
151,prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.2350742435750933,-0.910867191745854,0.6818181818181818,0.7978766281082067,1.0,15/63,17.83%,SLC25A5;VDAC3;SLC25A4;NOP56;PIK3CD;PUM2;MAP3K5;PSMB2;SEM1;ATP2A2;AKT1;ATP2A3;PIK3R1;PSMC2;RBPJ
152,prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.38071774510225986,0.9064116644936048,0.6549586776859504,1.0,1.0,17/62,19.97%,CDKN1A;BCL2A1;CDK9;MAX;SPI1;CEBPB;PML;BAK1;H3-3A;IL1R2;MMP9;ASPSCR1;BIRC3;RARA;DDIT3;CD14;TFE3
153,prerank,KEGG_2021_Human__Complement and coagulation cascades,0.4474190079022513,0.9039192896663862,0.6150943396226415,1.0,1.0,6/16,12.73%,SERPING1;C2;F2RL2;CD55;F12;C3AR1
154,prerank,KEGG_2021_Human__Serotonergic synapse,0.4292824178100039,0.9014375398119506,0.6202686202686203,1.0,1.0,10/20,26.55%,GNG10;PTGS2;CASP3;DUSP1;GNG5;GNB2;RAF1;ALOX5;GNB1;GNAI2
155,prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.38513300757651914,0.9010726520810068,0.6620320855614973,1.0,1.0,5/51,8.53%,UBE2L6;ALDOA;PSME1;LDHA;MCEE
156,prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.2385769829262928,-0.9002617616797088,0.7142857142857143,0.8066841575602203,1.0,10/62,9.69%,SFPQ;CDC25B;GSPT1;NCL;G3BP1;PRPF4B;SRSF2;AMD1;DR1;CDKN1B
157,prerank,KEGG_2021_Human__Peroxisome,0.4150238161562187,0.8919623715631212,0.6519721577726219,1.0,1.0,8/24,22.71%,SCP2;SOD2;XDH;HMGCL;FAR1;PEX2;ACSL5;SOD1
158,prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.38467260971576017,0.890485817970961,0.6497237569060773,1.0,1.0,5/41,9.23%,MAPK13;STAT1;CASP3;STAT5B;ICAM1
159,prerank,KEGG_2021_Human__Breast cancer,-0.2682227787008318,-0.8870520735935219,0.7037037037037037,0.8181691020519694,1.0,3/36,5.88%,NCOA3;HES1;PIK3CD
160,prerank,KEGG_2021_Human__Adherens junction,0.41780330634266244,0.8865405669495631,0.6402366863905326,1.0,1.0,9/21,27.01%,ACTG1;PTPN6;CSNK2B;CDC42;PTPRJ;ACTB;RHOA;TGFBR1;CTNNA1
161,prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.4205057646269426,0.8844672506543392,0.6474056603773585,1.0,1.0,3/21,11.29%,TRIM21;C2;H3-3A
162,prerank,KEGG_2021_Human__Cholinergic synapse,-0.2922271531335615,-0.8839284301254361,0.75,0.8054615894614878,1.0,3/27,5.88%,PRKACB;ADCY7;PIK3CD
163,prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.38109551492560934,0.8825134140375358,0.6875675675675675,1.0,1.0,18/48,29.90%,MAPK13;RPS6KA1;ARHGDIA;RIPK2;NFKBIB;MAPKAPK2;CDC42;ARHGDIB;NFKBIA;RAF1;RAP1B;IRAK4;RHOA;RELA;BAD;CRK;RAPGEF1;NRAS
164,prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.41961381091366867,0.8822941261594759,0.6572769953051644,1.0,1.0,2/22,2.14%,MAPK13;P2RY2
165,prerank,KEGG_2021_Human__Platelet activation,0.38283686559980007,0.880699396353262,0.6742424242424242,1.0,1.0,16/44,26.55%,MAPK13;FCER1G;VAMP8;ACTG1;MYL12A;MYL12B;PPP1CA;LCP2;VASP;RAP1B;ACTB;ORAI1;FERMT3;RHOA;PIK3R5;GNAI2
166,prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.27514197818927555,-0.8790413103844161,0.6888888888888889,0.7979241361607697,1.0,5/32,12.31%,AGPAT3;PLD3;LPCAT1;LYPLA1;DGKH
167,prerank,KEGG_2021_Human__Wnt signaling pathway,-0.27332812083306723,-0.8748914774606779,0.7058823529411765,0.7890184291222637,1.0,14/31,25.16%,PRKACB;SMAD4;CTBP1;PPP3CB;CSNK2A1;CACYBP;SENP2;CCND2;TCF7;CSNK2A2;CTNNB1;PLCB2;APC;NFATC3
168,prerank,KEGG_2021_Human__Lysosome,0.3671896310537283,0.8716810581267723,0.7013669821240799,1.0,1.0,12/57,16.32%,NAPSA;LAMP2;CTSS;CLTA;TCIRG1;SMPD1;CD63;CLN3;LITAF;CD164;CLN5;CTSE
169,prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.3958845189615357,0.8688030541640469,0.6621923937360179,1.0,1.0,12/27,27.11%,CSF3R;CSF1;CSF2RA;CD55;IL1R2;CD24;CD14;CD44;MME;IL1B;CR1L;ANPEP
170,prerank,MSigDB_Hallmark_2020__heme Metabolism,0.35768194459752345,0.86875490739778,0.7461617195496417,1.0,1.0,23/80,21.84%,LAMP2;SLC2A1;HBQ1;LPIN2;SDCBP;SIDT2;SLC66A2;CCND3;NFE2;CIR1;TNS1;TMEM9B;USP15;SLC7A11;CTSE;TOP1;GCLM;HTATIP2;FOXJ2;BLVRB;RNF19A;BMP2K;FBXO34
171,prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.367751771715925,0.8622400754237198,0.7199570815450643,1.0,1.0,13/50,20.94%,MAPK13;GNG10;PTGS2;NDUFB7;NDUFS6;DAGLB;NDUFA7;NDUFB3;NDUFA13;GNG5;NDUFS2;GNB2;NDUFA3
172,prerank,KEGG_2021_Human__Cell adhesion molecules,0.41345446327243196,0.858660592186944,0.6850117096018735,1.0,1.0,5/20,9.81%,CD274;SELPLG;CLDN1;ICAM1;CLDN5
173,prerank,KEGG_2021_Human__Non-small cell lung cancer,0.3765983265175387,0.8586261767321367,0.7126696832579186,1.0,1.0,10/36,30.19%,CDKN1A;STAT5B;BAK1;RAF1;RASSF5;STAT3;E2F2;BAD;NRAS;GADD45G
174,prerank,KEGG_2021_Human__MicroRNAs in cancer,0.3660526188200696,0.8561470662500719,0.7170418006430869,1.0,1.0,14/50,25.60%,CDKN1A;PTGS2;SOCS1;CASP3;BAK1;MMP9;MCL1;HMOX1;CD44;RAF1;RHOA;STAT3;UBE2I;E2F2
175,prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.3768350344897701,0.8557644884673389,0.7082405345211581,1.0,1.0,5/36,13.14%,MAPK13;STAT1;SOCS1;STAT5B;SOCS3
176,prerank,KEGG_2021_Human__Prostate cancer,0.38270753725440293,0.8509650613986146,0.7104959630911188,1.0,1.0,10/31,29.90%,CDKN1A;IL1R2;MMP9;GSTP1;NFKBIA;RAF1;RELA;E2F2;BAD;NRAS
177,prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.3642808131324129,0.8452768054984571,0.7328990228013029,1.0,1.0,11/44,25.41%,MAPK13;PTPN6;NFKBIB;CDC42;VAV1;LCP2;NFKBIA;NCK1;RAF1;RHOA;RELA
178,prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.3897149798961185,0.8429053226789077,0.7103448275862069,1.0,1.0,7/25,21.06%,TPI1;INPP1;MTMR3;ITPK1;IPMK;MTM1;MTMR14
179,prerank,KEGG_2021_Human__Melanoma,0.3856503950161839,0.832123704422835,0.7050359712230215,1.0,1.0,7/24,30.19%,CDKN1A;BAK1;RAF1;E2F2;BAD;NRAS;GADD45G
180,prerank,KEGG_2021_Human__AMPK signaling pathway,0.3612509564967587,0.8279554284882474,0.7505446623093682,1.0,1.0,12/38,28.05%,PRKAB1;EIF4EBP1;PFKL;RAB8A;ADIPOR2;PRKAA1;PFKFB4;CRTC2;PPP2R5A;CPT1A;RHEB;RAB14
181,prerank,KEGG_2021_Human__Insulin signaling pathway,0.35200400348668515,0.8252503151391797,0.7631296891747053,1.0,1.0,19/48,29.90%,MKNK1;PRKAB1;HK3;SOCS1;EIF4EBP1;PPP1R3B;FLOT2;SOCS3;PPP1CA;PRKAA1;PPP1R3D;RAF1;HK1;RHEB;BAD;PYGL;CRK;RAPGEF1;NRAS
182,prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.33759276967093593,0.8230321032144339,0.7895277207392197,1.0,1.0,28/85,29.90%,CSF3R;TLR2;CDKN1A;CSF1;GNG10;EIF4EBP1;CCND3;MCL1;TLR4;SGK3;GNG5;PRKAA1;GNB2;RAF1;CRTC2;PPP2R5A;SPP1;RELA;PIK3R5;IFNAR2;GNB1;RHEB;BAD;OSM;DDIT4;SYK;PKN2;NRAS
183,prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.3525043398904409,0.8156193157975978,0.7708108108108108,1.0,1.0,14/43,26.55%,CDKN1A;MYL6;PRKAB1;PTGS2;ACTG1;RGS2;PPP1CA;PRKAA1;TRPM2;RAF1;ACTB;RHOA;PIK3R5;GNAI2
184,prerank,KEGG_2021_Human__mTOR signaling pathway,0.3438352523493227,0.8130799047232431,0.7663451232583065,1.0,1.0,17/52,29.92%,TNFRSF1A;ATP6V1G1;LPIN2;EIF4EBP1;RPS6KA1;CLIP1;SLC3A2;PRKAA1;LAMTOR1;RAF1;LAMTOR4;RHOA;ATP6V1F;RHEB;DDIT4;NRAS;ATP6V1B2
185,prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.27664626709060475,-0.81285131654659,0.774390243902439,0.8927428648368229,1.0,2/21,2.74%,PRKACB;GNAS
186,prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.33143592515766107,0.812231324470151,0.8867735470941884,1.0,1.0,40/174,23.20%,MAPK13;TUBA4A;TNFRSF1A;PSMA5;UQCRHL;GABARAP;SQSTM1;CASP3;BID;NDUFB7;ACTG1;PSMD8;PFN1;NDUFS6;RAB8A;NDUFA7;SDHB;NDUFB3;NDUFA13;MCU;GABARAPL1;DNAH8;NDUFS2;DDIT3;COX6B1;ATP5PO;ADRM1;SETX;GPX1;PSMA1;COX8A;PSMA6;NDUFA3;ANXA11;DCTN5;CASP1;SOD1;PSMB3;TBK1;ACTB
187,prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.3949680339577747,0.809799278027929,0.7356181150550796,1.0,1.0,4/16,9.96%,PRKAB1;TPM4;TPM3;ACTG1
188,prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.35713771519165105,0.8090311731274438,0.7582417582417582,1.0,1.0,5/35,10.86%,FAS;NT5E;MGP;TPM4;TIMP1
189,prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.263853101199725,-0.7909174372303892,0.8092105263157895,0.9097241736157811,1.0,8/23,23.73%,NOP56;NOP58;IMP3;LSG1;TCOF1;CSNK2A1;POP7;CSNK2A2
190,prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.33514205292475857,0.7906566490955437,0.7876200640341515,1.0,1.0,15/53,30.19%,CDKN1A;MGST1;ACTG1;BAK1;HMOX1;KEAP1;GSTP1;RAF1;ACTB;E2F2;TGFBR1;BAD;GSTM1;NRAS;GADD45G
191,prerank,KEGG_2021_Human__Pancreatic secretion,0.3921584884336978,0.7884020520809611,0.758282208588957,1.0,1.0,4/16,12.80%,BST1;PLA2G5;RAB11A;RAB8A
192,prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.23258351326257032,-0.7870391706039225,0.8589743589743589,0.8959006967847709,1.0,10/42,17.61%,NCOA3;PRKACB;ATP1B3;PIK3CD;FOXO1;ATP2A2;AKT1;ATP2A3;SIN3A;PIK3R1
193,prerank,KEGG_2021_Human__Parkinson disease,0.3199733049797903,0.7847317966421413,0.8963782696177063,1.0,1.0,27/140,20.94%,UBE2L6;UBA7;TUBA4A;UBB;PSMA5;LRRK2;UQCRHL;CASP3;NDUFB7;PSMD8;NDUFS6;NDUFA7;SDHB;NDUFB3;NDUFA13;UBE2L3;MCU;DUSP1;NDUFS2;DDIT3;COX6B1;ATP5PO;ADRM1;PSMA1;COX8A;PSMA6;NDUFA3
194,prerank,KEGG_2021_Human__Notch signaling pathway,0.3677065912111315,0.7797736710902691,0.7554479418886199,1.0,1.0,6/20,20.26%,DTX3L;CIR1;TLE4;PSENEN;APH1B;NUMB
195,prerank,KEGG_2021_Human__Long-term depression,-0.2958971018142809,-0.776652955127209,0.7636363636363637,0.8901780951017806,1.0,1/16,2.74%,GNAS
196,prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.330152520968329,0.7739336032644917,0.8207547169811321,1.0,1.0,13/54,19.31%,PSMB8;CXCL10;FCER1G;CTSS;PTGS2;CSF2RA;LAT2;MMP9;C3AR1;BIRC3;LCP1;RETN;TRIB1
197,prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.3245077422264678,0.7686828848889798,0.8507772020725388,1.0,1.0,15/70,19.94%,CFL1;ARPC3;ARPC1B;LIMK2;ACTG1;PFN1;ARPC5;FGD3;MYL12A;MYL12B;CDC42;VAV1;PPP1CA;TMSB4Y;ARPC1A
198,prerank,KEGG_2021_Human__Relaxin signaling pathway,0.33498811656739613,0.766504621056047,0.8076923076923077,1.0,1.0,12/41,26.60%,MAPK13;GNG10;MMP9;ARRB2;GNG5;NFKBIA;GNB2;RAF1;RELA;GNB1;GNAI2;TGFBR1
199,prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.279963346916463,-0.7593920265058239,0.7934782608695652,0.8962510246834867,1.0,7/18,25.41%,MDH1;MDH2;CS;PDHA1;ACO2;ACLY;DLD
200,prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.3302410603721268,0.7556988743151367,0.8176733780760627,1.0,1.0,12/39,30.19%,CDKN1A;STAT5B;BAK1;NFKBIA;RAF1;RELA;E2F2;TGFBR1;BAD;CRK;NRAS;GADD45G
201,prerank,KEGG_2021_Human__Rap1 signaling pathway,0.32075018026567753,0.7555836800447999,0.8575916230366493,1.0,1.0,21/64,29.90%,MAPK13;FPR1;CSF1;ACTG1;PFN1;FYB1;CDC42;VAV1;LCP2;VASP;RAF1;RAP1B;ACTB;RASSF5;RHOA;RGS14;GNAI2;MAP2K3;CRK;RAPGEF1;NRAS
202,prerank,KEGG_2021_Human__Pancreatic cancer,0.33276453558404123,0.7549478224276645,0.8201997780244173,1.0,1.0,10/40,27.52%,CDKN1A;STAT1;BAK1;CDC42;RAF1;STAT3;RELA;E2F2;TGFBR1;BAD
203,prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.3082814962540702,0.7529227239170233,0.9037487335359676,1.0,1.0,21/104,21.13%,MAPK13;NCF2;UQCRHL;CYBA;SLC2A1;NDUFB7;NDUFS6;NCF4;MMP9;NDUFA7;SDHB;NDUFB3;NDUFA13;PPP1CA;NDUFS2;COX6B1;ATP5PO;PDHB;COX8A;NDUFA3;G6PD
204,prerank,KEGG_2021_Human__Endometrial cancer,0.3412752329019763,0.7489484968340091,0.8046783625730994,1.0,1.0,7/26,30.19%,CDKN1A;BAK1;RAF1;CTNNA1;BAD;NRAS;GADD45G
205,prerank,KEGG_2021_Human__Oxidative phosphorylation,0.30974870938764376,0.7468820344334329,0.8871794871794871,1.0,1.0,17/82,20.94%,UQCRHL;ATP6V1G1;COX17;TCIRG1;NDUFB7;NDUFS6;ATP6V0E1;ATP5MF;NDUFA7;SDHB;NDUFB3;NDUFA13;NDUFS2;COX6B1;ATP5PO;COX8A;NDUFA3
206,prerank,KEGG_2021_Human__MAPK signaling pathway,0.3067354532224188,0.7467008010717047,0.9085365853658537,1.0,1.0,9/93,9.06%,MAPK13;TNFRSF1A;FAS;CSF1;MKNK1;MAX;MYD88;CASP3;RPS6KA1
207,prerank,KEGG_2021_Human__Focal adhesion,0.3211030134211583,0.7457872704639272,0.8486772486772487,1.0,1.0,19/54,29.32%,ZYX;ACTG1;CCND3;MYL12A;BIRC3;MYL12B;CDC42;VAV1;PPP1CA;PARVG;VASP;RAF1;RAP1B;ACTB;RHOA;SPP1;BAD;CRK;RAPGEF1
208,prerank,KEGG_2021_Human__Amoebiasis,0.3355321741155801,0.7385264862648099,0.8152295632698768,1.0,1.0,7/29,18.56%,TLR2;ARG2;CASP3;IL1R2;TLR4;RAB7A;CD14
209,prerank,KEGG_2021_Human__Vibrio cholerae infection,0.3526048672597533,0.7376102137702735,0.8385236447520185,1.0,1.0,11/22,29.92%,ATP6V1G1;TCIRG1;ACTG1;ATP6V0E1;ACTB;SEC61G;ATP6V1F;KDELR2;SEC61A1;ARF1;ATP6V1B2
210,prerank,MSigDB_Hallmark_2020__Myogenesis,0.32912698393955925,0.7309804158628335,0.8580931263858093,1.0,1.0,8/37,20.79%,LSP1;CDKN1A;TPM3;IFRD1;SIRT2;BAG1;SPARC;SYNGR2
211,prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.3469816082141324,0.7309237548206508,0.8184049079754602,1.0,1.0,8/19,32.09%,SCP2;GCLM;ACSL5;SOD1;HSD17B11;PEX19;PEX16;CROT
212,prerank,KEGG_2021_Human__Hippo signaling pathway,-0.21625577972271176,-0.7261202125712031,0.9591836734693877,0.9134256307496129,1.0,15/34,25.94%,ID2;SMAD4;SMAD7;RASSF2;ITGB2;YWHAB;YWHAH;PPP2R2D;CCND2;SMAD2;TCF7;CTNNB1;APC;TGFB1;PPP1CC
213,prerank,KEGG_2021_Human__Dopaminergic synapse,0.32358819777536685,0.7204616045344174,0.8497237569060774,1.0,1.0,9/34,26.55%,MAPK13;GNG10;ARRB2;PPP1CA;GNG5;GNB2;PPP2R5A;GNB1;GNAI2
214,prerank,MSigDB_Hallmark_2020__Adipogenesis,0.2952800151035396,0.7164495123027682,0.9102040816326531,1.0,1.0,25/86,26.67%,ALDOA;SCP2;PLIN2;TALDO1;RNF11;NDUFB7;ENPP2;IFNGR1;STOM;PFKL;SDHB;ADIPOR2;POR;RETN;ATP5PO;COX8A;GRPEL1;RTN3;SOD1;ETFB;GPD2;CD302;GHITM;LPCAT3;TKT
215,prerank,KEGG_2021_Human__Prion disease,0.2914337082948812,0.715496405704821,0.963673057517659,1.0,1.0,26/146,20.94%,MAPK13;TUBA4A;NCF2;PSMA5;UQCRHL;CYBA;CASP3;NDUFB7;PSMD8;NDUFS6;NCF4;NDUFA7;SDHB;NDUFB3;NDUFA13;MCU;CSNK2B;NDUFS2;DDIT3;COX6B1;ATP5PO;ADRM1;PSMA1;COX8A;PSMA6;NDUFA3
216,prerank,KEGG_2021_Human__Cardiac muscle contraction,0.3418717132182844,0.7136292316704099,0.8433014354066986,1.0,1.0,3/20,9.13%,UQCRHL;TPM4;TPM3
217,prerank,KEGG_2021_Human__Acute myeloid leukemia,0.3102962627121401,0.7038174327155764,0.8734602463605823,1.0,1.0,5/35,9.57%,BCL2A1;SPI1;EIF4EBP1;STAT5B;PML
218,prerank,MSigDB_Hallmark_2020__Pperoxisome,0.3087404886138362,0.6999111387331747,0.8722466960352423,1.0,1.0,5/34,13.04%,TSPO;SCP2;SOD2;HMGCL;FIS1
219,prerank,KEGG_2021_Human__Ras signaling pathway,0.2960502078233338,0.6980628474492323,0.9044652128764278,1.0,1.0,17/60,27.52%,ETS2;CSF1;GNG10;PLA2G5;CDC42;GNG5;GNB2;RAF1;RAP1B;TBK1;RASSF5;RHOA;RELA;RAB5A;GNB1;BRAP;BAD
220,prerank,KEGG_2021_Human__Cellular senescence,0.2948942511165414,0.6964414538709248,0.9077412513255567,1.0,1.0,9/61,17.42%,MAPK13;CDKN1A;SQSTM1;EIF4EBP1;CCND3;MCU;MAPKAPK2;LIN37;PPP1CA
221,prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.2914256938716009,0.6957571188376915,0.9166666666666666,1.0,1.0,8/63,16.61%,TUBA4A;ARL8A;LMNB1;ARHGDIA;ARHGAP27;MAPRE1;CLIP1;CDC42
222,prerank,KEGG_2021_Human__Alzheimer disease,0.2787855866797686,0.6911693021173099,0.972972972972973,0.9981226364184598,1.0,32/175,22.15%,TUBA4A;TNFRSF1A;FAS;PSMA5;EIF2AK2;UQCRHL;CSF1;PTGS2;CASP3;BID;NDUFB7;PSMD8;NDUFS6;NDUFA7;PSENEN;SDHB;NDUFB3;NDUFA13;MCU;CSNK2B;NDUFS2;DDIT3;COX6B1;ATP5PO;ADRM1;APH1B;PSMA1;COX8A;PSMA6;NDUFA3;RAF1;RTN3
223,prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.29614234006828927,0.671790659101746,0.9060109289617486,1.0,1.0,4/39,9.13%,MAPK13;CREM;TPM4;TPM3
224,prerank,KEGG_2021_Human__Colorectal cancer,0.29339920984187284,0.6663089472575892,0.9010989010989011,1.0,1.0,3/40,10.74%,CDKN1A;CASP3;BAK1
225,prerank,KEGG_2021_Human__Mitophagy,0.2918222367422549,0.6659227702650311,0.9010989010989011,1.0,1.0,11/35,23.10%,UBB;GABARAP;SQSTM1;USP15;FIS1;RAB7A;CSNK2B;GABARAPL1;TFE3;HIF1A;TBK1
226,prerank,KEGG_2021_Human__Glioma,0.2964853271437531,0.6466848579592885,0.8979833926453143,1.0,1.0,2/27,10.74%,CDKN1A;BAK1
227,prerank,KEGG_2021_Human__Protein export,0.32027112509596056,0.636707427716396,0.9208899876390606,1.0,1.0,8/15,31.50%,SEC11C;SRP19;SEC11A;SEC61G;SEC62;SEC61A1;SRPRA;SPCS2
228,prerank,KEGG_2021_Human__Huntington disease,0.25787719091120853,0.6315902239479393,0.9909365558912386,1.0,1.0,27/148,22.95%,TUBA4A;PSMA5;UQCRHL;SOD2;CLTA;TBPL1;CASP3;NDUFB7;PSMD8;NDUFS6;NDUFA7;SDHB;NDUFB3;NDUFA13;DNAH8;NDUFS2;COX6B1;ATP5PO;ADRM1;GPX1;PSMA1;COX8A;PSMA6;NDUFA3;DCTN5;SOD1;PSMB3
229,prerank,KEGG_2021_Human__Axon guidance,0.27593416290455053,0.6272630227159387,0.9433333333333334,1.0,1.0,9/36,21.81%,CFL1;LIMK2;FES;MYL12A;MYL12B;SEMA4D;CDC42;NCK1;RAF1
230,prerank,KEGG_2021_Human__Cell cycle,0.2815091211519504,0.6269481858946051,0.939799331103679,1.0,1.0,3/35,10.10%,CDKN1A;CDKN2D;CCND3
231,prerank,KEGG_2021_Human__Chemical carcinogenesis,0.25220968667858734,0.6040680179300977,0.964021164021164,1.0,1.0,8/57,15.16%,PTGS2;EIF4EBP1;MGST1;STAT5B;RPS6KA1;CCND3;ARRB2;GSTP1
232,prerank,KEGG_2021_Human__Thermogenesis,0.247687954469115,0.603791903189424,0.9878419452887538,1.0,1.0,20/108,21.01%,MAPK13;UQCRHL;PRKAB1;COX17;NDUFB7;RPS6KA1;ACTG1;NDUFS6;ATP5MF;NDUFA7;SDHB;NDUFB3;NDUFA13;NDUFS2;PRKAA1;COX6B1;ATP5PO;COX8A;NDUFA3;ACSL5
233,prerank,MSigDB_Hallmark_2020__Androgen Response,0.26036157897191814,0.5851610480825802,0.9657458563535911,1.0,1.0,11/36,25.16%,B2M;CCND3;STEAP4;MYL12A;TPD52;SRP19;ADRM1;TNFAIP8;TMEM50A;PIAS1;UBE2I
234,prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.2450372368742877,0.5667342682111364,0.974585635359116,1.0,1.0,9/43,22.03%,DAPP1;LILRB2;FCGR2B;PTPN6;NFKBIB;VAV1;NFKBIA;RAF1;LILRA6
235,prerank,KEGG_2021_Human__Longevity regulating pathway,0.23311326173449862,0.5396008640173062,0.9825136612021858,1.0,1.0,3/40,8.14%,PRKAB1;SOD2;EIF4EBP1
236,prerank,MSigDB_Hallmark_2020__Protein Secretion,0.23047258844881152,0.5348224593919786,0.9892933618843683,1.0,1.0,15/47,29.97%,LAMP2;CLTA;CD63;CLN5;TPD52;TSG101;NAPA;SOD1;RER1;RAB5A;RAB14;STX7;SNX2;ARF1;TMED2
237,prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.21083452482203216,0.48589093653110316,0.9978925184404637,1.0,1.0,4/48,11.93%,DNAJC3;CEBPB;EIF4EBP1;SERP1
238,prerank,KEGG_2021_Human__Gastric cancer,0.2048245705709607,0.46704584762617013,1.0,1.0,1.0,2/37,10.74%,CDKN1A;BAK1
239,prerank,KEGG_2021_Human__GnRH secretion,0.20964670286981882,0.4298993967386098,0.9910256410256411,1.0,1.0,4/16,29.90%,ARRB2;RAF1;SPP1;NRAS
240,prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.1687064545487827,0.39889628849988124,1.0,1.0,1.0,23/81,34.44%,EIF2AK2;DNAJC3;UBXN1;BAK1;UBE2D3;BAG1;DDIT3;SAR1B;DNAJC5;SEC61G;LMAN2;TXNDC5;SEC62;SEC61A1;UBE2J2;BCAP31;RRBP1;UBXN4;PPP1R15A;UFD1;SEL1L;CKAP4;DERL2
241,prerank,KEGG_2021_Human__Choline metabolism in cancer,0.15692684114947947,0.35182351493907965,1.0,0.9998818407394952,1.0,12/33,38.96%,EIF4EBP1;RAF1;HIF1A;CHPT1;RHEB;NRAS;GPCPD1;DGKA;RAC2;PIP5K1A;SOS2;PIP5K1C
